Atlas Trials

Exemestane or Docetaxel-Cytoxan in Low Recurrence Score Cancers

Clinical trial NCT00941330 · COMPLETED

Trial details

NCT number
NCT00941330
Sponsor
Emory University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2009-07-01
Primary completion
2015-05-01
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.